Clinical Evaluation of Rega 8: An Updated Genotypic Interpretation System That Significantly Predicts HIV-Therapy Response
Open Access
- 17 April 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (4) , e61436
Abstract
Clinically evaluating genotypic interpretation systems is essential to provide optimal guidance in designing potent individualized HIV-regimens. This study aimed at investigating the ability of the latest Rega algorithm to predict virological response on a short and longer period. 9231 treatment changes episodes were extracted from an integrated patient database. The virological response after 8, 24 and 48 weeks was dichotomized to success and failure. Success was defined as a viral load below 50 copies/ml or alternatively, a 2 log decrease from the baseline viral load at 8 weeks. The predictive ability of Rega version 8 was analysed in comparison with that of previous evaluated version Rega 5 and two other algorithms (ANRS v2011.05 and Stanford HIVdb v6.0.11). A logistic model based on the genotypic susceptibility score was used to predict virological response, and additionally, confounding factors were added to the model. Performance of the models was compared using the area under the ROC curve (AUC) and a Wilcoxon signed-rank test. Per unit increase of the GSS reported by Rega 8, the odds on having a successful therapy response on week 8 increased significantly by 81% (OR = 1.81, CI = [1.76–1.86]), on week 24 by 73% (OR = 1.73, CI = [1.69–1.78]) and on week 48 by 85% (OR = 1.85, CI = [1.80–1.91]). No significant differences in AUC were found between the performance of Rega 8 and Rega 5, ANRS v2011.05 and Stanford HIVdb v6.0.11, however Rega 8 had the highest sensitivity: 76.9%, 76.5% and 77.2% on 8, 24 and 48 weeks respectively. Inclusion of additional factors increased the performance significantly. Rega 8 is a significant predictor for virological response with a better sensitivity than previously, and with rules for recently approved drugs. Additional variables should be taken into account to ensure an effective regimen.Keywords
This publication has 24 references indexed in Scilit:
- Interpretation of Genotypic HIV-1 Resistance to Darunavir and Virological Response: Validation of Available Systems and of a New ScoreAntiviral Therapy, 2011
- Comparison of HIV-1 Genotypic Resistance Test Interpretation Systems in Predicting Virological Outcomes Over TimePLOS ONE, 2010
- Predictive Value of HIV‐1 Genotypic Resistance Test Interpretation AlgorithmsThe Journal of Infectious Diseases, 2009
- Rules-based HIV-1 genotypic resistance interpretation systems predict 8 week and 24 week virological antiretroviral treatment outcome and benefit from drug potency weightingJournal of Antimicrobial Chemotherapy, 2009
- Predicting the Response to Combination Antiretroviral Therapy: Retrospective Validation of geno2pheno‐THEO on a Large Clinical DatabaseThe Journal of Infectious Diseases, 2009
- The Management of Treatment‐Experienced HIV‐Infected Patients: New Drugs and Drug CombinationsClinical Infectious Diseases, 2009
- The incidence of multidrug and full class resistance in HIV-1 infected patients is decreasing over time (2001–2006) in PortugalRetrovirology, 2008
- The ability of four genotypic interpretation systems to predict virological response to ritonavir-boosted protease inhibitorsAIDS, 2007
- Web Resources for HIV Type 1 Genotypic-Resistance Test InterpretationClinical Infectious Diseases, 2006
- Changing patterns of mortality across Europe in patients infected with HIV-1The Lancet, 1998